| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 29.8 | 56.8 | 31.0 |
| Other income | 0.8 | 0.9 | 0.3 |
| Total income | 30.6 | 57.7 | 31.4 |
| Profit before exceptional items & tax | 2.6 | 1.0 | -3.9 |
| Exceptional items | 1.5 | 0.3 | 0.0 |
| Profit before tax | 1.1 | 0.7 | -3.9 |
| Net profit | 1.1 | 0.7 | -4.1 |
| Operating margin | 3.6% | 1.2% | -12.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +57.10% |
|---|---|
| Revenue, year on year | -3.90% |
BSE results filing, NSE: GKB. Figures extracted from the filing.
GKB Ophthalmics Ltd: key numbers
- Share price
- ₹66.09
- Market cap
- ₹33.31 Cr
- Revenue (annual)
- ₹149.1 Cr
- Net profit (annual)
- ₹1.22 Cr
- P/E (TTM)
- 10.3×Sector 57.8×
- Promoter holding
- 51.15%+0.02% QoQ
- FII holding
- 1.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GKB Ophthalmics Ltd
All →GKB Ophthalmics Annual General Meeting
GKB Ophthalmics filed minutes of its 44th AGM held on 25 August 2026. It approved financial statements and re-appointed directors, declaring no dividend due to operating losses.
GKB Ophthalmics Q1 FY27 Results: Turns Profitable, Net Profit ₹1.8 Cr
GKB Ophthalmics Ltd reported revenue from operations of ₹33 Cr (+2.2% YoY) and net profit of ₹1.8 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr